Application Information

This drug has been submitted to the FDA under the reference 204009/001.

Names and composition

"DESVENLAFAXINE" is the commercial name of a drug composed of DESVENLAFAXINE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
204009/001 DESVENLAFAXINE DESVENLAFAXINE TABLET, EXTENDED RELEASE/ORAL 50MG
204009/002 DESVENLAFAXINE DESVENLAFAXINE TABLET, EXTENDED RELEASE/ORAL 100MG
204150/001 DESVENLAFAXINE DESVENLAFAXINE TABLET, EXTENDED RELEASE/ORAL 50MG
204150/002 DESVENLAFAXINE DESVENLAFAXINE TABLET, EXTENDED RELEASE/ORAL 100MG
205208/001 DESVENLAFAXINE DESVENLAFAXINE FUMARATE TABLET, EXTENDED RELEASE/ORAL EQ 50MG BASE
205208/002 DESVENLAFAXINE DESVENLAFAXINE FUMARATE TABLET, EXTENDED RELEASE/ORAL EQ 100MG BASE
205583/001 DESVENLAFAXINE DESVENLAFAXINE FUMARATE TABLET, EXTENDED RELEASE/ORAL EQ 50MG BASE
205583/002 DESVENLAFAXINE DESVENLAFAXINE FUMARATE TABLET, EXTENDED RELEASE/ORAL EQ 100MG BASE

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
204009/001 DESVENLAFAXINE DESVENLAFAXINE TABLET, EXTENDED RELEASE/ORAL 50MG
204009/002 DESVENLAFAXINE DESVENLAFAXINE TABLET, EXTENDED RELEASE/ORAL 100MG
204150/001 DESVENLAFAXINE DESVENLAFAXINE TABLET, EXTENDED RELEASE/ORAL 50MG
204150/002 DESVENLAFAXINE DESVENLAFAXINE TABLET, EXTENDED RELEASE/ORAL 100MG
204683/001 KHEDEZLA DESVENLAFAXINE TABLET, EXTENDED RELEASE/ORAL 50MG
204683/002 KHEDEZLA DESVENLAFAXINE TABLET, EXTENDED RELEASE/ORAL 100MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved